Benzinga | May 17, 2021 04:15PM EDT

AcelRx Pharmaceuticals Q1 EPS $(0.08), Inline, Sales $500.00K Miss $1.06M Estimate

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 60 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $500.00 thousand which missed the analyst consensus estimate of $1.06 million by 52.83 percent. This is a 29.53 percent increase over sales of $386.00 thousand the same period last year.